Ceravision maintains an extensive Intellectual Property (IP) portfolio comprising Patents, Trade Marks and Design Rights. We have developed a significant Patent portfolio around our novel electrodeless plasma light source. This Patent portfolio continues to expand as patent applications are granted and new filings are registered in various jurisdictions Ceravision's patent portfolio currently comprises 31 Patent Families, 27 PCT applications in 15 jurisdictions and 129 Granted Patents with 36 in application. In developing its new horticulture UV grow-light, Ceravision has continued to enhance its valuable intellectual property portfolio.
Ceravision maintains a broad patenting strategy in terms of both technical and geographical extent. All aspects of the Company's lighting technology have been protected, with patents added to the portfolio as new inventions are created and developed. We have secured protection in: Europe, USA, Japan, North America, the GCC region, Brazil, Russia, India, China, Australasia and Africa.
Ceravision has successfully followed a strict policy of vigorously protecting and enforcing its IP rights worldwide and will continue to do so.
Delivering flexible spectral outputs, Ceravision's lighting offers practical economic solutions in horticulture and other applications including UV-B lights to help production of vitamin D in reptiles and humans, and UV sterilisation.
HEP Plasma Lighting Technology
Ceravision’s HEP plasma grow-lights, with a spectrum providing UV-B, UV-A and blue herald a new scientific future in horticulture lighting and UV-B is beneficial for humans producing the vitamin D essential for health.
Ceravision maintains an extensive Intellectual Property (“IP”) portfolio comprising Patents, Trade Marks and Design Rights.